PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pathology, Stanford University, Stanford, California, USA.\', \'Department of Hematology, Kaiser Permanente, Renton, Washington, USA.\', \'Department of Medicine, Quantitative Sciences Unit, Stanford University, Stanford, California, USA.\', \'Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA.\', \'Stanford Blood Center, Stanford, California, USA.\', \'Department of Emergency Medicine, Stanford University, Stanford, California, USA.\', \'Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Stanford University, Stanford, California, USA.\', \'Department of Medicine, Division of Hematology, Stanford University, Stanford, California, USA.\', \'Chemistry, Engineering, & Medicine for Human Health Institute (ChEM-H), Stanford University, Stanford, California, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/trf.16711
?:doi
?:hasPublicationType
?:journal
  • Transfusion
is ?:pmid of
?:pmid
?:pmid
  • 34677830
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.645
?:rankingScore_hIndex
  • 120
?:title
  • Active surveillance of serious adverse events following transfusion of COVID-19 convalescent plasma.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all